These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31870644)

  • 21. Phenotypic signatures of genetic frontotemporal dementia.
    Rohrer JD; Warren JD
    Curr Opin Neurol; 2011 Dec; 24(6):542-9. PubMed ID: 21986680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
    Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
    Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.
    Domínguez-Vivero C; Wu L; Lee S; Manoochehri M; Cines S; Brickman AM; Rizvi B; Chesebro A; Gazes Y; Fallon E; Lynch T; Heidebrink JL; Paulson H; Goldman JS; Huey E; Cosentino S
    J Alzheimers Dis; 2020; 75(2):595-606. PubMed ID: 32310161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN.
    Whitwell JL; Weigand SD; Gunter JL; Boeve BF; Rademakers R; Baker M; Knopman DS; Wszolek ZK; Petersen RC; Jack CR; Josephs KA
    Neurology; 2011 Jul; 77(4):393-8. PubMed ID: 21753165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.
    Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM
    Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Globular glial tauopathy with a mutation in MAPT and unusual TDP-43 proteinopathy in a patient with behavioural-variant frontotemporal dementia.
    Forrest SL; Shepherd CE; McCann H; Kwok JB; Halliday GM; Kril JJ
    Acta Neuropathol; 2021 May; 141(5):791-794. PubMed ID: 33744978
    [No Abstract]   [Full Text] [Related]  

  • 27. Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.
    Sellami L; Bocchetta M; Masellis M; Cash DM; Dick KM; van Swieten J; Borroni B; Galimberti D; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Finger E; de Mendonça A; Sorbi S; Warren JD; Rohrer JD; Laforce R;
    J Alzheimers Dis; 2018; 65(1):147-163. PubMed ID: 30010122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.
    Tacik P; DeTure MA; Carlomagno Y; Lin WL; Murray ME; Baker MC; Josephs KA; Boeve BF; Wszolek ZK; Graff-Radford NR; Parisi JE; Petrucelli L; Rademakers R; Isaacson RS; Heilman KM; Petersen RC; Dickson DW; Kouri N
    Brain Pathol; 2017 Sep; 27(5):612-626. PubMed ID: 27529406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
    Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
    Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma tau is increased in frontotemporal dementia.
    Foiani MS; Woollacott IO; Heller C; Bocchetta M; Heslegrave A; Dick KM; Russell LL; Marshall CR; Mead S; Schott JM; Fox NC; Warren JD; Zetterberg H; Rohrer JD
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):804-807. PubMed ID: 29440230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXP2 Expression in Frontotemporal Lobar Degeneration-Tau.
    López-González I; Palmeira A; Aso E; Carmona M; Fernandez L; Ferrer I
    J Alzheimers Dis; 2016 Sep; 54(2):471-5. PubMed ID: 27497476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinsonian syndrome in familial frontotemporal dementia.
    Siuda J; Fujioka S; Wszolek ZK
    Parkinsonism Relat Disord; 2014 Sep; 20(9):957-64. PubMed ID: 24998994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M).
    Domoto-Reilly K; Davis MY; Keene CD; Bird TD
    Am J Med Genet B Neuropsychiatr Genet; 2017 Jan; 174(1):70-74. PubMed ID: 26990251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of Frontotemporal Dementia.
    Olszewska DA; Lonergan R; Fallon EM; Lynch T
    Curr Neurol Neurosci Rep; 2016 Dec; 16(12):107. PubMed ID: 27878525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.
    Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR
    Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function.
    Iyer A; Lapointe NE; Zielke K; Berdynski M; Guzman E; Barczak A; Chodakowska-Żebrowska M; Barcikowska M; Feinstein S; Zekanowski C
    PLoS One; 2013; 8(9):e76409. PubMed ID: 24086739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.
    Ghetti B; Oblak AL; Boeve BF; Johnson KA; Dickerson BC; Goedert M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):24-46. PubMed ID: 25556536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
    Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
    Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene.
    Olszewska DA; Fearon C; McGuigan C; McVeigh TP; Houlden H; Polke JM; Lawlor B; Coen R; Hutchinson M; Hutton M; Beausang A; Delon I; Brett F; Sevastou I; Seto-Salvia N; de Silva R; Lynch T
    Neurobiol Aging; 2021 Oct; 106():343.e1-343.e8. PubMed ID: 34274155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.
    Vinceti G; Olney N; Mandelli ML; Spina S; Hubbard HI; Santos-Santos MA; Watson C; Miller ZA; Lomen-Hoerth C; Nichelli P; Miller BL; Grinberg LT; Seeley WW; Gorno-Tempini ML
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):146-158. PubMed ID: 30668155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.